Identification of new markers discriminating between myeloid and lymphoid acute leukemia

Hematology

Volumn 15, Issue 4, 2010, Pages 193-203

  Haouas, Houda ^a   Haouas, Samira ^b   Uzan, Georges ^c   Hafsia, Aïcha ^d  

^a UNIVERSITY OF CARTHAGE   (Tunisia)

^b FACULTÉ DES SCIENCES DE TUNIS   (Tunisia)

^c INSERM   (France)

^d Hopital Aziza Othmana   (Tunisia)

Author keywords

Acute leukemia; diagnosis; molecular markers; prognosis

Indexed keywords

AMPHIREGULIN; CERULOPLASMIN; GUANINE NUCLEOTIDE BINDING PROTEIN GAMMA 11; GUANINE NUCLEOTIDE BINDING PROTEIN GAMMA SUBUNIT; TUMOR MARKER; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LEUKEMIA; BLOOD CELL; CANCER CLASSIFICATION; CELL LINEAGE; CLINICAL ARTICLE; DOWN REGULATION; FEMALE; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T CELL LEUKEMIA; UNINDEXED SEQUENCE; UPREGULATION;

ADOLESCENT; ADULT; AGED; CELL LINE, TUMOR; CERULOPLASMIN; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; GLYCOPROTEINS; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA, MYELOID, ACUTE; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 77955180595     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453310X12647083620769     Document Type: Article

References (32)

1. Mrozek K, Marcucci G, Paschka P, Whitman SP, Bloomfield CD. Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification? Blood 2007; 109: 431-448
2. Summers K, Stevens J, Kakkas I et al. Wilm's tumor 1 mutations are associated with FLT3-ITD and failure of standard induction chemotherapy in patients with normal karyotype AML. Leukemia 2007; 21: 550-551
3. Frohling S, Schlenk RF, Stolze I et al. CEBPA mutations in younger adults with acute myeloid leukemia and normal cytoge-netics: prognostic relevance and analysis of cooperating mutations. J Clin Oncol 2004; 22: 624-633
4. Thielde C, Koch S, Creutzig E et al. Prevalence and prognostic impact of NPM1 mutations in 1,485 adult patients with acute myeloid leukemia (AML). Blood 2006; 107: 4011-4020
5. Baldus CD, Thiede C, Soucek S, Bloomfield CD, Thiel E, Ehninger G. BAALC and FLT3 internal tandem duplication mutations in acute myeloid leukemia patients with normal cytogenetics; prognostic implications. J Clin Oncol 2006; 24: 790-797
6. Marcucci G, Maharry K, Whitman SP et al. High expression levels of ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study. J Clin Oncol 2007; 25: 3337-3343
7. Heuser M, Beutel G, Krauter J et al. High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics. Blood 2006; 108: 3898-3905
8. Dohner K, Tobis K, Ulrich R et al. Prognostic significance of partial tandem duplication of the MLL gene in adult patients 16 and 60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm. J Clin Oncol 2002; 20: 3254-3261
9. Bennet JM, Catovsky D, Daniel MT et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American- British Cooperative Group. Ann Intern Med 1985; 103: 620-625
10. Vladimir JW, Harris NL, Brunning RD. The World Health Organisation (WHO) classification of the myeloid neoplasms. Blood 2002; 100: 2292-2302
11. Golub T, Slonim D, Tamayo P et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999; 286: 531-537
12. Valk P, Verhaak R, Beijen M et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 2004; 350: 1617-1628
13. Haferlach T, Kohlmann A, Schnittger S et al. A global approach to the diagnosis of leukemia using gene expression profiling. Blood 2005; 106: 1189-1198
14. Bullinger L, Dohner K, Bair E et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 2004; 350: 1605-1616
15. Wilson CS, Davidson GS, Martin SB et al. Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction. Blood 2006; 108: 685-696
16. Court EL, Smith MA, Avent ND et al. Microarray screening of differential gene expression in bone marrow samples from AML, non-AML patients and AML cell lines. Leukemia Res 2004; 28: 743-753
17. Grimwade D, Haferlach T. Gene expression profiling in acute myeloid leukemia. N Engl J Med 2004; 350: 1676-1678
18. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002; 30: 207-210
19. Rhodes D, Yu J, Shanker K et al. ONCOMINE: a cancer microarray database and data-mining platform. Neoplasia 2004; 6: 1-6
20. Parkinson H, Sarkans U, Shojatalab M et al. ArrayExpress-a public repository for microarray gene expression data at the EBI. Nucleic Acids Res 2005; 33(Database issue): D553-D555
21. Larkin J, Frank B, Gavras H, Sultana R, Quackenbush J. Independence and reproducibility across microarray platforms. Nat Methods 2005; 2: 337-344
22. Bammler T, Beyer R, Bhattacharya S et al. Standardizing global gene expression analysis between laboratories and across platforms. Nat Methods 2005; 2: 351-356
23. Irizarry R, Warren D, Spencer F et al. Multiple laboratory comparison of microarray platforms. Nat Methods 2005; 2: 345-350
24. Staal FJT, Cario G, Cazzaniga G et al. Consensus guidelines for microarray gene expression analyses in leukemia from three European leukemia networks. Leukemia 2006; 20: 1385-1392
25. Thomas JG, Olson JM, Tapscott SJ, Zhao LP. An efficient and robust statistical modeling approach to discover differentially expressed genes using genomic expression profiles. Genome Res 2001; 11: 1227-1236
26. Nilsson B, Andersson A, Johanson M, Fioretos A. Cross-platform classification in microarray-based leukemia diagnosis. Haematologica 2006; 91: 821-824
27. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159
28. Tusher VG, Tibbshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98: 5116-5121
29. Koeffler HP, Billing R, Lusis AJ, Sparkes R, Golde DW. An undifferentiated variant derived from the human acute myelogen-ous leukemia cell line (KG-1). Blood 1980; 56: 265-273
30. Martin P, Papayannopoulou T. HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression. Science 1982; 216: 1233-1235
31. Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F, Berger R. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 1991; 77: 1080-1086
32. Lozzio CB, Lozzio BB. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 1975; 45: 321-334